Pharmalot.. Pharmalittle.. Good Morning: We’re Catching up on Glaxo, J&J and Lots More!!

By

Ed Silverman

Jul 9, 2015 9:01 am ET

Hello, everyone, and how are you today? We are doing just fine, thank you. Despite some gloomy clouds hovering overhead, our spirits remain sunny. After all, every brand new day should be unwrapped like a precious gift. So why not celebrate a wee bit? We are doing so, in fact, with yet another cup of delicious stimulation – we are back to southern pecan – and invite you to join us. Anything to help the neurons stay awake, right? Meanwhile, here are some tidbits to get you going. Have a smashing day and keep in touch…

HIV drugs are proving to be so effective in containing the virus that GlaxoSmithKline foresees a time, a decade away, when its most profitable business unit may no longer have a purpose; An inexpensive, little-known cholera vaccine appears to be work so well that it can protect entire communities and perhaps head off explosive epidemics like the one that killed nearly 10,000 Haitians in 2010; and UC San Diego has filed a lawsuit accusing USC and a nationally recognized Alzheimer’s disease researcher of allegedly conspiring to take federal funding, data and employees from a UC San Diego study center on the illness.